Abstract
Purpose
Previous analyses of the tumor microenvironment (TME) have resulted in a concept that tumor progression may depend on interactions between cancer cells and its surrounding stroma. An important aspect of these interactions is the ability of cancer cells to modulate stroma behavior, and vice versa, through the action of a variety of soluble mediators. Here, we aimed to identify soluble factors present in the TME of colorectal cancer cells that may affect relevant pathways through secretome profiling.
Methods
To partially recapitulate the TME and its architecture, we co-cultured colorectal cancer cells (SW480, TC) with stromal fibroblasts (MRC-5, F) as 3D-spheroids. Subsequent characterization of both homotypic (TC) and heterotypic (TC + F) spheroid secretomes was performed using label-free liquid chromatography-mass spectrometry (LC-MS).
Results
Through bioinformatic analysis using the NCI-Pathway Interaction Database (NCI-PID) we found that the HIF-1 signaling pathway was most highly enriched among the proteins whose secretion was enhanced in the heterotypic spheroids. Previously, we found that HIF-1 may be associated with resistance of colorectal cancer cells to photodynamic therapy (PDT), an antitumor therapy that combines photosensitizing agents, O2 and light to create a harmful photochemical reaction. Here, we found that the presence of fibroblasts considerably diminished the sensitivity of colorectal cancer cells to photodynamic activity. Although the biological significance of the HIF-1 pathway of secretomes was decreased after photosensitization, this decrease was partially reversed in heterotypic 3D-spheroids. HIF-1 pathway modulation by both PDT and stromal fibroblasts was confirmed through expression assessment of the HIF-target VEGF, as well as through HIF transcriptional activity assessment.
Conclusion
Collectively, our results delineate a potential mechanism by which stromal fibroblasts may enhance colorectal cancer cell survival and photodynamic treatment resistance via HIF-1 pathway modulation.
Similar content being viewed by others
Abbreviations
- 3D:
-
Three dimensional
- AGC:
-
Automatic gain control
- CRC:
-
Colorectal cancer
- DMSO:
-
Dimethyl sulfoxide
- ENO1:
-
Enolase 1
- F:
-
Fibroblast
- FBS:
-
Fetal bovine serum
- GFP:
-
Green fluorescent protein
- GLUT-1:
-
Glucose transporter 1
- HCD:
-
High energy collision induced dissociation
- HIF-1:
-
Hypoxia inducible factor-1
- LDHA:
-
Lactate dehydrogenase
- LC-MS:
-
Liquid chromatography–Mass spectrometry
- LFQ:
-
Label-free quantification
- Me-ALA:
-
Aminolevulinic acid methyl ester
- MTT:
-
1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan
- NCI-PID:
-
National Cancer Institute–Pathway Interaction Database
- NPM1:
-
Nucleophosmin
- PAI-1:
-
Plasminogen activator inhibitor 1
- PBS:
-
Phosphate buffer saline
- PpIX:
-
Protoporphyrin IX
- PS:
-
Photosensitizer
- TC:
-
Tumor cell
- TFRC:
-
Transferrin receptor protein 1
- VEGF:
-
Vascular endothelial growth factor
References
P. Nilendu, S. Sarode, D. Jahagirdar, I. Tandon, S. Patil, G. Sarode, J. Pal, N. Sharma, Mutual concessions and compromises between stromal cells and cancer cells: Driving tumor development and drug resistance. Cell. Oncol. 41, 353 (2018)
N. Eiro, L. González, A. Martínez-Ordoñez, B. Fernandez-Garcia, L. González, S. Cid, F. Dominguez, R. Perez-Fernandez, F. Vizoso, Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis. Cell. Oncol. 41, 369 (2018)
P. Cirri, P. Chiarugi, Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31, 195 (2012)
J. Paltridge, L. Belle, Y. Khew-Goodall, Advances in the proteomic investigation of the cell secretome. Biochim. Biophys. Acta 1834, 2233 (2013)
K. Brown, C. Formolo, H. Seol, R. Marathi, S. Duguez, E. An, D. Pillai, J. Nazarian, B. Rood, Y. Hathout, Advances in the proteomic investigation of the cell secretome. Expert Rev. Proteomics 9, 337 (2012)
D. Hanahan, L. Coussens, Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309 (2012)
D. Hanahan, R. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646 (2011)
P. Agostinis, E. Buytaert, H. Breyssens, N. Hendrickx, Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 3, 721 (2004)
N. Rumie Vittar, M. Lamberti, M. Pansa, R. Vera, M. Rodriguez, I. Cogno, L. Milla Sanabria, V. Rivarola, Ecological photodynamic therapy: New trend to disrupt the intricate networks within tumor ecosystem. Biochim. Biophys. Acta 1835, 86 (2013)
A. Kawczyk-Krupka, A. Bugaj, W. Latos, K. Zaremba, K. Wawrzyniec, A. Sieroń, Photodynamic therapy in colorectal cancer treatment: The state of the art in clinical trials. Photodiagn. Photodyn. Ther. 12, 545 (2015)
M. Lamberti, M. Pansa, R. Vera, M. Fernandez-Zapico, N. Rumie Vittar, V. Rivarola, Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy. PLoS One 12, e0177801 (2017)
M. Rodríguez, C. Catrinacio, A. Ropolo, V. Rivarola, M. Vaccaro, A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells. Photochem. Photobiol. Sci. 16, 1631 (2017)
U. Brockmeier, C. Platzek, K. Schneider, P. Patak, A. Bernardini, J. Fandrey, E. Metzen, The function of hypoxia-inducible factor (HIF) is independent of the endoplasmic reticulum protein OS-9. PLoS One 6, e19151 (2011)
M. Pansa, M. Lamberti, I. Cogno, S. Correa, N. Rumie Vittar, V. Rivarola, Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment. Tumour Biol. 37, 541 (2016)
W. Metzger, D. Sossong, A. Bächle, N. Pütz, G. Wennemuth, T. Pohlemann, M. Oberringer, The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells. Cytotherapy 13, 1000 (2011)
M. Lamberti, M. Pansa, R. Vera, N. Rumie Vittar, V. Rivarola, Photodynamic therapy potentiates the paracrine endothelial stimulation by colorectal cancer. Laser Phys. 24, 8 (2014)
G. Comito, E. Giannoni, P. Di Gennaro, C. Segura, G. Gerlini, P. Chiarugi, Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Lett. 324, 31 (2012)
C. Hughes, S. Foehr, D. Garfield, E. Furlong, L. Steinmetz, J. Krijgsveld, Ultrasensitive proteome analysis using paramagnetic bead technology. Mol. Syst. Biol. 10, 10 (2014)
J. Gouw, J. Krijgsveld, MSQuant: A platform for stable isotope-based quantitative proteomics. Methods Mol. Biol. 893, 511 (2012)
M. Arntzen, I. Karlskås, M. Skaugen, V. Eijsink, G. Mathiesen, Proteomic investigation of the response of enterococcus faecalis V583 when cultivated in urine. PLoS One 10, e0126694 (2015)
Y. Zhang, Z. Dong, D. Wang, Y. Wu, Q. Song, P. Gu, P. Zhao, Q. Xia, Proteomics of larval hemolymph in Bombyx mori reveals various nutrient-storage and immunity-related proteins. Amino Acids 46, 1021 (2014)
J. Bendtsen, L. Jensen, N. Blom, G. Von Heijne, S. Brunak, Eature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349 (2004)
T. Petersen, S. Brunak, G. von Heijne, H. Nielsen, SignalP 4.0: Discriminating signal peptides from transmembrane regions. Nat. Methods 8, 785 (2011)
C. von Mering, M. Huynen, D. Jaeggi, S. Schmidt, P. Bork, B. Snel, STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 31, 258 (2003)
C. Schaefer, K. Anthony, S. Krupa, J. Buchoff, M. Day, T. Hannay, K. Buetow, PID: The pathway interaction database. Nucleic Acids Res. 37, D674 (2009)
M. Ashburner, C. Ball, J. Blake, D. Botstein, H. Butler, J. Cherry, A. Davis, K. Dolinski, S. Dwight, J. Eppig, M. Harris, D. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. Matese, J. Richardson, M. Ringwald, G. Rubin, G. Sherlock, Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25 (2000)
M. Lamberti, N. Rumie Vittar, F. de Carvalho da Silva, V. Ferreira, V. Rivarola, Synergistic enhancement of antitumor effect of B-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Phytomedicine 20, 1007 (2013)
C. Hellweg, C. Baumstark-Khan, G. Horneck, Enhanced green fluorescent protein as reporter protein for biomonitoring of cytotoxic effects in mammalian cells. Anal. Chim. Acta 427, 191 (2001)
L. Milla, I. Cogno, M. Rodríguez, F. Sanz-Rodríguez, A. Zamarrón, Y. Gilaberte, E. Carrasco, V. Rivarola, A. Juarranz, Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy. J. Cell. Biochem. 112, 2266 (2011)
V.G. Peddareddigari, D. Wang, R.N. Dubois, The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron. 3, 149 (2010)
C. Koumenis, L. Coussens, A. Giaccia, E. Hammond, Tumor Microenvironment: Study Protocols, vol. 899 (Springer, 2016)
T. Tsujino, I. Seshimo, H. Yamamoto, C. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, M. Monden, Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer Res. 13, 2082 (2007)
G. Karagiannis, M. Pavlou, E. Diamandis, Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 4, 496 (2010)
H. Soares, J. Campos, L. Gomes-da-Silva, F. Schaberle, J. Dabrowski, L. Arnaut, Pro-oxidant and antioxidant effects in photodynamic therapy: Cells recognise that not all exogenous ROS are alike. Chembiochem 17, 836 (2016)
M.D. Glidden, I. Massodi, I. Rizvi, J.P. Celli, T. Hasan, Probing tumor-stroma interactions and response to photodynamic therapy in a 3D pancreatic cancer-fibroblast co-culture model. Proc. SPIE 8210, 821006 (2012)
K. Lauber, A. Ernst, M. Orth, M. Herrmann, C. Belka, Dying cell clearance and its impact on the outcome of tumor radiotherapy. Front. Oncol. 2, 116 (2012)
V. Carroll, M. Ashcroft, Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway. Cancer Res. 66, 6264 (2006)
T. Wu, Y. Dai, Tumor microenvironment and therapeutic response. Cancer Lett. 387, 61 (2017)
S. Sant, P. Johnston, The production of 3D tumor spheroids for cancer drug discovery. Drug Discov. Today Technol. 23, 27 (2017)
M. Zanoni, F. Piccinini, C. Arienti, A. Zamagni, S. Santi, R. Polico, A. Bevilacqua, A. Tesei, 3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Sci. Rep. 6, 19103 (2016)
A. Amann, M. Zwierzina, G. Gamerith, M. Bitsche, J. Huber, G. Vogel, M. Blumer, S. Koeck, E. Pechriggl, J. Kelm, W. Hilbe, H. Zwierzina, Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells. PLoS One 9, e92511 (2014)
L. Villarreal, O. Méndez, C. Salvans, J. Gregori, J. Baselga, J. Villanueva, Unconventional secretion is a major contributor of cancer cell line secretomes. Mol. Cell. Proteomics 12, 1046 (2013)
G. Butler, C. Overall, proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat. Rev. Drug Discov. 8, 935 (2009)
D. Radisky, M. Stallings-Mann, Y. Hirai, M. Bissell, Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat. Rev. Mol. Cell Biol. 10, 228 (2009)
D. Fukumura, R. Xavier, T. Sugiura, Y. Chen, E. Park, N. Lu, M. Selig, G. Nielsen, T. Taksir, R. Jain, B. Seed, Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715 (1998)
R. Kalluri, M. Zeisberg, Fibroblasts in cancer. Nat. Rev. Cancer 6, 392 (2006)
C. Holohan, S. Van Schaeybroeck, D. Longley, P. Johnston, Cancer drug resistance: An evolving paradigm. Nat. Rev. Cancer 13, 714 (2013)
S. Jung, H. Song, S. Park, S. Chung, Y. Kim, Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression. Int. J. Oncol. 38, 571 (2011)
Y. Ahn, M. Chua, J.J. Whitlock, Y. Shin, W. Song, Y. Kim, C. Eom, W. An, Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells. Int. J. Oncol. 37, 1627 (2010)
S. Peng, G. Xue, L. Gong, C. Fang, J. Chen, C. Yuan, Z. Chen, L. Yao, B. Furie, M. Huang, A long-acting PAI-1 inhibitor reduce thrombus formation. Thromb. Haemost. 117, 1338 (2017)
G. McMahon, E. Petitclerc, S. Stefansson, E. Smith, M. Wong, R. Westrick, D. Ginsburg, P. Brooks, D. Lawrence, Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 276, 33964 (2001)
C. Isogai, W. Laug, H. Shimada, P. Declerck, M. Stins, D. Durden, A. Erdreich-Epstein, Y. DeClerck, Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res. 61, 5587 (2001)
R. Gozzelino, P. Arosio, Iron homeostasis in health and disease. Int. J. Mol. Sci. 17, (2016)
I. Toth, L. Yuan, J. Rogers, H. Boyce, K. Bridges, Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J. Biol. Chem. 274, 4467 (1999)
L. Tacchini, L. Bianchi, A. Bernelli-Zazzera, G. Cairo, Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142 (1999)
L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, G. Cairo, Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J. Biol. Chem. 283, 20674 (2008)
A. de Gassart, C. Geminard, B. Fevrier, G. Raposo, M. Vidal, Lipid raft-associated protein sorting in exosomes. Blood 102, 4336 (2003)
A. Calzolari, C. Raggi, S. Deaglio, N. Sposi, M. Stafsnes, K. Fecchi, I. Parolini, F. Malavasi, C. Peschle, M. Sargiacomo, U. Testa, TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J. Cell Sci. Pt 21, 4486 (119AD)
M.I. Koukourakis, A. Giatromanolaki, A.L. Harris, E. Sivridis, Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Res. 66, 632 (2006)
G. van Niekerk, A. Engelbrecht, Role of PKM2 in directing the metabolic fate of glucose in cancer: A potential therapeutic target. Cell. Oncol. 41, 343 (2018)
R. Han, F. Wang, P. Zhang, X. Zhou, Y. Li, miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA. Neoplasma 64 (2017)
T. He, Y. Zhang, H. Jiang, X. Li, H. Zhu, K. Zheng, The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Med. Oncol. 32, 187 (2015)
M. Capello, S. Ferri-Borgogno, P. Cappello, F. Novelli, α-Enolase: A promising therapeutic and diagnostic tumor target. FEBS J. 287, 1064 (2011)
C. Hu, A. Sataur, L. Wang, H. Chen, M. Simon, The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol. Biol. Cell 18, 4528 (2007)
G. Semenza, B. Jiang, S. Leung, R. Passantino, J. Concordet, P. Maire, A. Giallongo, Hypoxia response elements in the aldolase a, enolase 1, and lactate dehydrogenase a gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 27, 32529 (1996)
N. Denko, Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705 (2008)
M. Demory Beckler, J. Higginbotham, J. Franklin, A. Ham, P. Halvey, I. Imasuen, C. Whitwell, M. Li, D. Liebler, R. Coffey, Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol. Cell. Proteomics 12, 343 (2013)
R. Xu, D. Greening, A. Rai, H. Ji, R. Simpson, Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods 87, 11 (2015)
D. Choi, J. Lee, G. Park, H. Lim, J. Bang, Y. Kim, K. Kwon, H. Kwon, K. Kim, Y. Gho, Proteomic analysis of microvesicles derived from human colorectal cancer cells. J. Proteome Res. 6, 4646 (2007)
S. Mathivanan, J. Lim, B. Tauro, H. Ji, R. Moritz, R. Simpson, Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 9, 197 (2010)
R. Borer, C. Lehner, H. Eppenberger, E. Nigg, Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56, 379 (1989)
R. Redner, Variations on a theme: The alternate translocations in APL. Leukemia 16, 1927 (2002)
N. Yoneda-Kato, A. Look, M. Kirstein, M. Valentine, S. Raimondi, K. Cohen, A. Carroll, S. Morris, The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12, 265 (1996)
R. Chiarle, J. Gong, I. Guasparri, A. Pesci, J. Cai, J. Liu, W. Simmons, G. Dhall, J. Howes, R. Piva, G. Inghirami, NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101, 1919 (2003)
N. van Belzen, M. Diesveld, A. van der Made, Y. Nozawa, W. Dinjens, R. Vlietstra, J. Trapman, F. Bosman, Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. Eur. J. Biochem. 234, 843 (1995)
N. Feuerstein, J. Mond, Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. J. Immunol. 139, 1818 (1987)
J. Li, X. Zhang, D. Sejas, G. Bagby, Q. Pang, Hypoxia-induced Nucleophosmin protects cell death through inhibition of p53. J. Biol. Chem. 279, 41275 (2004)
D. Taylor, C. Gerçel-Taylor, Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92, 305 (2005)
Acknowledgements
This work was supported by grants from the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Agencia Nacional de Promoción Científica y Tecnológica (PICT), Secretaría de Ciencia y Técnica (SECyT), Universidad Nacional de Río Cuarto, and a Christian Boulin Fellowship (EMBL). VAR and NBRV are members of the Scientific Researcher Career at CONICET. MJL holds a fellowship from CONICET.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
None declared.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Table S1
Perseus correlation matrix. Correlation coefficients whose magnitude were greater than 0.7 were considered highly correlated (red numbers indicate correlation values <0.7) (DOCX 19 kb)
Table S2
List of proteins identified in homotypic spheroids secretome. Available information: ID identified according to UniProt, name of the protein, corresponding gene, location of the signal peptide in those proteins secreted by the classical pathway (SignalP), NN-score of proteins secreted by non-classical pathways (SecretomeP, the NN-score should be greater than 0.5), LFQ (“label-free quantification”) value (mean and standard deviation). (DOCX 33 kb)
Table S3
List of proteins identified in heterotypic spheroids secretome. Available information: ID identified according to UniProt, name of the protein, corresponding gene, location of the signal peptide in those proteins secreted by the classical pathway (SignalP), NN-score of proteins secreted by non-classical pathways (SecretomeP, the NN-score should be greater than 0.5), LFQ (“label-free quantification”) value (mean and standard deviation). (DOCX 36 kb)
Table S4
List of proteins identified in PDT-treated homotypic spheroids secretome. Available information: ID identified according to UniProt, name of the protein, corresponding gene, location of the signal peptide in those proteins secreted by the classical pathway (SignalP), NN-score of proteins secreted by non-classical pathways (SecretomeP, the NN-score should be greater than 0.5), LFQ (“label-free quantification”) value (mean and standard deviation). (DOCX 45 kb)
Table S5
List of proteins identified in PDT-treated heterotypic spheroids secretome. Available information: ID identified according to UniProt, name of the protein, corresponding gene, location of the signal peptide in those proteins secreted by the classical pathway (SignalP), NN-score of proteins secreted by non-classical pathways (SecretomeP, the NN-score should be greater than 0.5), LFQ (“label-free quantification”) value (mean and standard deviation). (DOCX 55 kb)
Fig S1
Histograms. Histograms were performed using the logarithmic LFQ values (log10 (x)) to visualize the normal distribution of the data (Perseus software) (JPG 63 kb)
Fig S2
Multiscatter plot. The multiscatter plot was performed using the logarithmic LFQ values (log2 (x)) to visualize the correlation between the replicates (JPG 220 kb)
Fig S3
Gene Ontology. (A) Biological process classification in Gene Ontology analysis of proteins whose secretion was enhanced in in photosensitized homotypic spheroids compared to untreated ones. (B) Biological process classification in Gene Ontology analysis of proteins whose secretion was enhanced in in photosensitized heterotypic spheroids compared to untreated ones. (PNG 980 kb)
Rights and permissions
About this article
Cite this article
Lamberti, M.J., Rettel, M., Krijgsveld, J. et al. Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance. Cell Oncol. 42, 173–196 (2019). https://doi.org/10.1007/s13402-018-00418-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-018-00418-8